|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 11 (June 1), 2000:
pp. 3387-3395
Up-regulation of vascular endothelial growth factor receptor Flt-1
after endothelial denudation: role of transcription factor Egr-1
Felipe Vidal,
Julián Aragonés,
Arántzazu Alfranca, and
Manuel O. de
Landázuri
From the Servicio de Inmunología, Hospital de la Princesa,
Universidad Autónoma de Madrid, Madrid, Spain.
Vascular endothelial growth factor (VEGF) is highly expressed in
vascular remodeling processes and accelerates reendothelialization after mechanical denudation. Two VEGF tyrosine kinase receptors have
been reported fms-like-tyrosine kinase-1 (Flt-1) and kinase domain region (KDR). Little is known about the regulation of the expression of these receptors after vascular injury. Herein, we have
analyzed the expression of Flt-1 after mechanical denudation of primary
cultures of endothelial cells, which has been considered a useful in
vitro model to study endothelium responses to vascular injury. After
denudation, the Flt-1 protein and mRNA levels are clearly up-regulated,
and transient transfection experiments showed a strong induction of the
flt-1 promoter-dependent transcription. Analysis
of the flt-1 promoter sequence revealed the presence of a
putative binding site for the early growth response factor-1 (Egr-1) at
positions  24 to 16. Electrophoretic mobility shift and supershift assays showed that Egr-1 was able to bind to this DNA
sequence, and cotransfection of the flt-1 promoter reporter plasmid with an Egr-1 expression vector resulted in enhancement of its
transcriptional activity. Furthermore, the mutation of the Egr-1
binding site markedly reduced the denudation-induced flt-1
promoter activity. These data demonstrate that Flt-1 is up-regulated
after endothelial denudation and that Egr-1 plays a relevant role in
this process.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. Khomenko, S. Szabo, X. Deng, M. R. Jadus, H. Ishikawa, K. Osapay, Z. Sandor, and L. Chen
Suppression of early growth response factor-1 with egr-1 antisense oligodeoxynucleotide aggravates experimental duodenal ulcers
Am J Physiol Gastrointest Liver Physiol,
June 1, 2006;
290(6):
G1211 - G1218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Yamaguchi, S.-H. Lee, J.-S. Kim, J. Wimalasena, S. Kitajima, and S. J. Baek
Activating Transcription Factor 3 and Early Growth Response 1 Are the Novel Targets of LY294002 in a Phosphatidylinositol 3-Kinase-Independent Pathway
Cancer Res.,
February 15, 2006;
66(4):
2376 - 2384.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Khachigian
Early Growth Response-1 in Cardiovascular Pathobiology
Circ. Res.,
February 3, 2006;
98(2):
186 - 191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Malakooti, R. Sandoval, V. C. Memark, P. K. Dudeja, and K. Ramaswamy
Zinc finger transcription factor Egr-1 is involved in stimulation of NHE2 gene expression by phorbol 12-myristate 13-acetate
Am J Physiol Gastrointest Liver Physiol,
October 1, 2005;
289(4):
G653 - G663.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Zagzag, B. Krishnamachary, H. Yee, H. Okuyama, L. Chiriboga, M. A. Ali, J. Melamed, and G. L. Semenza
Stromal Cell-Derived Factor-1{alpha} and CXCR4 Expression in Hemangioblastoma and Clear Cell-Renal Cell Carcinoma: von Hippel-Lindau Loss-of-Function Induces Expression of a Ligand and Its Receptor
Cancer Res.,
July 15, 2005;
65(14):
6178 - 6188.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Minami, A. Sugiyama, S.-Q. Wu, R. Abid, T. Kodama, and W. C. Aird
Thrombin and Phenotypic Modulation of the Endothelium
Arterioscler Thromb Vasc Biol,
January 1, 2004;
24(1):
41 - 53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Lloyd, B. M. Prior, H. T. Yang, and R. L. Terjung
Angiogenic growth factor expression in rat skeletal muscle in response to exercise training
Am J Physiol Heart Circ Physiol,
May 1, 2003;
284(5):
H1668 - H1678.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Lucerna, D. Mechtcheriakova, A. Kadl, G. Schabbauer, R. Schafer, F. Gruber, Y. Koshelnick, H.-D. Muller, K. Issbrucker, M. Clauss, et al.
NAB2, a Corepressor of EGR-1, Inhibits Vascular Endothelial Growth Factor-mediated Gene Induction and Angiogenic Responses of Endothelial Cells
J. Biol. Chem.,
March 21, 2003;
278(13):
11433 - 11440.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-Q. Wu, T. Minami, D. J. Donovan, and W. C. Aird
The proximal serum response element in the Egr-1 promoter mediates response to thrombin in primary human endothelial cells
Blood,
December 15, 2002;
100(13):
4454 - 4461.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Minami, D. J. Donovan, J. C. Tsai, R. D. Rosenberg, and W. C. Aird
Differential regulation of the von Willebrand factor and Flt-1 promoters in the endothelium of hypoxanthine phosphoribosyltransferase-targeted mice
Blood,
December 1, 2002;
100(12):
4019 - 4025.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. N. Bochkov, D. Mechtcheriakova, M. Lucerna, J. Huber, R. Malli, W. F. Graier, E. Hofer, B. R. Binder, and N. Leitinger
Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca++/NFAT
Blood,
January 1, 2002;
99(1):
199 - 206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
